Global Consumer Healthcare Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 358512
  • calendar_today Published On: Jun, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

According to our latest study, the global Consumer Healthcare Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.

This report is a detailed and comprehensive analysis for global Consumer Healthcare Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Consumer Healthcare Drug market size and forecasts, in consumption value ($ Million), 2018-2029

Global Consumer Healthcare Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Consumer Healthcare Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Consumer Healthcare Drug market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Consumer Healthcare Drug

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Consumer Healthcare Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, AbbVie, Merck & Co., GlaxoSmithKline and Pfizer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Consumer Healthcare Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Solid Preparations

Oral Liquid

Patch

Other

Market segment by Application

Hospital

Retail Pharmacy

Other

Market segment by players, this report covers

Johnson & Johnson

AbbVie

Merck & Co.

GlaxoSmithKline

Pfizer

Sanofi

Takeda

Bayer

Teva

Sinopharm Group

CR Pharmaceutical

Shanghai Pharmaceuticals

Hualan Bio

North China Pharmaceutical

Hengrui Medicine

Fosun Pharma

East China Medicine

Livzon Group

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Argentina and Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Consumer Healthcare Drug product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Consumer Healthcare Drug, with revenue, gross margin and global market share of Consumer Healthcare Drug from 2018 to 2023.

Chapter 3, the Consumer Healthcare Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Consumer Healthcare Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Consumer Healthcare Drug.

Chapter 13, to describe Consumer Healthcare Drug research findings and conclusion.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Consumer Healthcare Drug

1.2 Market Estimation Caveats and Base Year

1.3 Classification of Consumer Healthcare Drug by Type

1.3.1 Overview: Global Consumer Healthcare Drug Market Size by Type: 2018 Versus 2022 Versus 2029

1.3.2 Global Consumer Healthcare Drug Consumption Value Market Share by Type in 2022

1.3.3 Solid Preparations

1.3.4 Oral Liquid

1.3.5 Patch

1.3.6 Other

1.4 Global Consumer Healthcare Drug Market by Application

1.4.1 Overview: Global Consumer Healthcare Drug Market Size by Application: 2018 Versus 2022 Versus 2029

1.4.2 Hospital

1.4.3 Retail Pharmacy

1.4.4 Other

1.5 Global Consumer Healthcare Drug Market Size & Forecast

1.6 Global Consumer Healthcare Drug Market Size and Forecast by Region

1.6.1 Global Consumer Healthcare Drug Market Size by Region: 2018 VS 2022 VS 2029

1.6.2 Global Consumer Healthcare Drug Market Size by Region, (2018-2029)

1.6.3 North America Consumer Healthcare Drug Market Size and Prospect (2018-2029)

1.6.4 Europe Consumer Healthcare Drug Market Size and Prospect (2018-2029)

1.6.5 Asia-Pacific Consumer Healthcare Drug Market Size and Prospect (2018-2029)

1.6.6 South America Consumer Healthcare Drug Market Size and Prospect (2018-2029)

1.6.7 Middle East and Africa Consumer Healthcare Drug Market Size and Prospect (2018-2029)

2 Company Profiles

2.1 Johnson & Johnson

2.1.1 Johnson & Johnson Details

2.1.2 Johnson & Johnson Major Business

2.1.3 Johnson & Johnson Consumer Healthcare Drug Product and Solutions

2.1.4 Johnson & Johnson Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Johnson & Johnson Recent Developments and Future Plans

2.2 AbbVie

2.2.1 AbbVie Details

2.2.2 AbbVie Major Business

2.2.3 AbbVie Consumer Healthcare Drug Product and Solutions

2.2.4 AbbVie Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 AbbVie Recent Developments and Future Plans

2.3 Merck & Co.

2.3.1 Merck & Co. Details

2.3.2 Merck & Co. Major Business

2.3.3 Merck & Co. Consumer Healthcare Drug Product and Solutions

2.3.4 Merck & Co. Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 Merck & Co. Recent Developments and Future Plans

2.4 GlaxoSmithKline

2.4.1 GlaxoSmithKline Details

2.4.2 GlaxoSmithKline Major Business

2.4.3 GlaxoSmithKline Consumer Healthcare Drug Product and Solutions

2.4.4 GlaxoSmithKline Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 GlaxoSmithKline Recent Developments and Future Plans

2.5 Pfizer

2.5.1 Pfizer Details

2.5.2 Pfizer Major Business

2.5.3 Pfizer Consumer Healthcare Drug Product and Solutions

2.5.4 Pfizer Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 Pfizer Recent Developments and Future Plans

2.6 Sanofi

2.6.1 Sanofi Details

2.6.2 Sanofi Major Business

2.6.3 Sanofi Consumer Healthcare Drug Product and Solutions

2.6.4 Sanofi Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 Sanofi Recent Developments and Future Plans

2.7 Takeda

2.7.1 Takeda Details

2.7.2 Takeda Major Business

2.7.3 Takeda Consumer Healthcare Drug Product and Solutions

2.7.4 Takeda Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 Takeda Recent Developments and Future Plans

2.8 Bayer

2.8.1 Bayer Details

2.8.2 Bayer Major Business

2.8.3 Bayer Consumer Healthcare Drug Product and Solutions

2.8.4 Bayer Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 Bayer Recent Developments and Future Plans

2.9 Teva

2.9.1 Teva Details

2.9.2 Teva Major Business

2.9.3 Teva Consumer Healthcare Drug Product and Solutions

2.9.4 Teva Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 Teva Recent Developments and Future Plans

2.10 Sinopharm Group

2.10.1 Sinopharm Group Details

2.10.2 Sinopharm Group Major Business

2.10.3 Sinopharm Group Consumer Healthcare Drug Product and Solutions

2.10.4 Sinopharm Group Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 Sinopharm Group Recent Developments and Future Plans

2.11 CR Pharmaceutical

2.11.1 CR Pharmaceutical Details

2.11.2 CR Pharmaceutical Major Business

2.11.3 CR Pharmaceutical Consumer Healthcare Drug Product and Solutions

2.11.4 CR Pharmaceutical Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 CR Pharmaceutical Recent Developments and Future Plans

2.12 Shanghai Pharmaceuticals

2.12.1 Shanghai Pharmaceuticals Details

2.12.2 Shanghai Pharmaceuticals Major Business

2.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Product and Solutions

2.12.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 Shanghai Pharmaceuticals Recent Developments and Future Plans

2.13 Hualan Bio

2.13.1 Hualan Bio Details

2.13.2 Hualan Bio Major Business

2.13.3 Hualan Bio Consumer Healthcare Drug Product and Solutions

2.13.4 Hualan Bio Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.13.5 Hualan Bio Recent Developments and Future Plans

2.14 North China Pharmaceutical

2.14.1 North China Pharmaceutical Details

2.14.2 North China Pharmaceutical Major Business

2.14.3 North China Pharmaceutical Consumer Healthcare Drug Product and Solutions

2.14.4 North China Pharmaceutical Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.14.5 North China Pharmaceutical Recent Developments and Future Plans

2.15 Hengrui Medicine

2.15.1 Hengrui Medicine Details

2.15.2 Hengrui Medicine Major Business

2.15.3 Hengrui Medicine Consumer Healthcare Drug Product and Solutions

2.15.4 Hengrui Medicine Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.15.5 Hengrui Medicine Recent Developments and Future Plans

2.16 Fosun Pharma

2.16.1 Fosun Pharma Details

2.16.2 Fosun Pharma Major Business

2.16.3 Fosun Pharma Consumer Healthcare Drug Product and Solutions

2.16.4 Fosun Pharma Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.16.5 Fosun Pharma Recent Developments and Future Plans

2.17 East China Medicine

2.17.1 East China Medicine Details

2.17.2 East China Medicine Major Business

2.17.3 East China Medicine Consumer Healthcare Drug Product and Solutions

2.17.4 East China Medicine Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.17.5 East China Medicine Recent Developments and Future Plans

2.18 Livzon Group

2.18.1 Livzon Group Details

2.18.2 Livzon Group Major Business

2.18.3 Livzon Group Consumer Healthcare Drug Product and Solutions

2.18.4 Livzon Group Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)

2.18.5 Livzon Group Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Consumer Healthcare Drug Revenue and Share by Players (2018-2023)

3.2 Market Share Analysis (2022)

3.2.1 Market Share of Consumer Healthcare Drug by Company Revenue

3.2.2 Top 3 Consumer Healthcare Drug Players Market Share in 2022

3.2.3 Top 6 Consumer Healthcare Drug Players Market Share in 2022

3.3 Consumer Healthcare Drug Market: Overall Company Footprint Analysis

3.3.1 Consumer Healthcare Drug Market: Region Footprint

3.3.2 Consumer Healthcare Drug Market: Company Product Type Footprint

3.3.3 Consumer Healthcare Drug Market: Company Product Application Footprint

3.4 New Market Entrants and Barriers to Market Entry

3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Consumer Healthcare Drug Consumption Value and Market Share by Type (2018-2023)

4.2 Global Consumer Healthcare Drug Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

5.1 Global Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2023)

5.2 Global Consumer Healthcare Drug Market Forecast by Application (2024-2029)

6 North America

6.1 North America Consumer Healthcare Drug Consumption Value by Type (2018-2029)

6.2 North America Consumer Healthcare Drug Consumption Value by Application (2018-2029)

6.3 North America Consumer Healthcare Drug Market Size by Country

6.3.1 North America Consumer Healthcare Drug Consumption Value by Country (2018-2029)

6.3.2 United States Consumer Healthcare Drug Market Size and Forecast (2018-2029)

6.3.3 Canada Consumer Healthcare Drug Market Size and Forecast (2018-2029)

6.3.4 Mexico Consumer Healthcare Drug Market Size and Forecast (2018-2029)

7 Europe

7.1 Europe Consumer Healthcare Drug Consumption Value by Type (2018-2029)

7.2 Europe Consumer Healthcare Drug Consumption Value by Application (2018-2029)

7.3 Europe Consumer Healthcare Drug Market Size by Country

7.3.1 Europe Consumer Healthcare Drug Consumption Value by Country (2018-2029)

7.3.2 Germany Consumer Healthcare Drug Market Size and Forecast (2018-2029)

7.3.3 France Consumer Healthcare Drug Market Size and Forecast (2018-2029)

7.3.4 United Kingdom Consumer Healthcare Drug Market Size and Forecast (2018-2029)

7.3.5 Russia Consumer Healthcare Drug Market Size and Forecast (2018-2029)

7.3.6 Italy Consumer Healthcare Drug Market Size and Forecast (2018-2029)

8 Asia-Pacific

8.1 Asia-Pacific Consumer Healthcare Drug Consumption Value by Type (2018-2029)

8.2 Asia-Pacific Consumer Healthcare Drug Consumption Value by Application (2018-2029)

8.3 Asia-Pacific Consumer Healthcare Drug Market Size by Region

8.3.1 Asia-Pacific Consumer Healthcare Drug Consumption Value by Region (2018-2029)

8.3.2 China Consumer Healthcare Drug Market Size and Forecast (2018-2029)

8.3.3 Japan Consumer Healthcare Drug Market Size and Forecast (2018-2029)

8.3.4 South Korea Consumer Healthcare Drug Market Size and Forecast (2018-2029)

8.3.5 India Consumer Healthcare Drug Market Size and Forecast (2018-2029)

8.3.6 Southeast Asia Consumer Healthcare Drug Market Size and Forecast (2018-2029)

8.3.7 Australia Consumer Healthcare Drug Market Size and Forecast (2018-2029)

9 South America

9.1 South America Consumer Healthcare Drug Consumption Value by Type (2018-2029)

9.2 South America Consumer Healthcare Drug Consumption Value by Application (2018-2029)

9.3 South America Consumer Healthcare Drug Market Size by Country

9.3.1 South America Consumer Healthcare Drug Consumption Value by Country (2018-2029)

9.3.2 Brazil Consumer Healthcare Drug Market Size and Forecast (2018-2029)

9.3.3 Argentina Consumer Healthcare Drug Market Size and Forecast (2018-2029)

10 Middle East & Africa

10.1 Middle East & Africa Consumer Healthcare Drug Consumption Value by Type (2018-2029)

10.2 Middle East & Africa Consumer Healthcare Drug Consumption Value by Application (2018-2029)

10.3 Middle East & Africa Consumer Healthcare Drug Market Size by Country

10.3.1 Middle East & Africa Consumer Healthcare Drug Consumption Value by Country (2018-2029)

10.3.2 Turkey Consumer Healthcare Drug Market Size and Forecast (2018-2029)

10.3.3 Saudi Arabia Consumer Healthcare Drug Market Size and Forecast (2018-2029)

10.3.4 UAE Consumer Healthcare Drug Market Size and Forecast (2018-2029)

11 Market Dynamics

11.1 Consumer Healthcare Drug Market Drivers

11.2 Consumer Healthcare Drug Market Restraints

11.3 Consumer Healthcare Drug Trends Analysis

11.4 Porters Five Forces Analysis

11.4.1 Threat of New Entrants

11.4.2 Bargaining Power of Suppliers

11.4.3 Bargaining Power of Buyers

11.4.4 Threat of Substitutes

11.4.5 Competitive Rivalry

11.5 Influence of COVID-19 and Russia-Ukraine War

11.5.1 Influence of COVID-19

11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

12.1 Consumer Healthcare Drug Industry Chain

12.2 Consumer Healthcare Drug Upstream Analysis

12.3 Consumer Healthcare Drug Midstream Analysis

12.4 Consumer Healthcare Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Consumer Healthcare Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Consumer Healthcare Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Global Consumer Healthcare Drug Consumption Value by Region (2018-2023) & (USD Million)

Table 4. Global Consumer Healthcare Drug Consumption Value by Region (2024-2029) & (USD Million)

Table 5. Johnson & Johnson Company Information, Head Office, and Major Competitors

Table 6. Johnson & Johnson Major Business

Table 7. Johnson & Johnson Consumer Healthcare Drug Product and Solutions

Table 8. Johnson & Johnson Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 9. Johnson & Johnson Recent Developments and Future Plans

Table 10. AbbVie Company Information, Head Office, and Major Competitors

Table 11. AbbVie Major Business

Table 12. AbbVie Consumer Healthcare Drug Product and Solutions

Table 13. AbbVie Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 14. AbbVie Recent Developments and Future Plans

Table 15. Merck & Co. Company Information, Head Office, and Major Competitors

Table 16. Merck & Co. Major Business

Table 17. Merck & Co. Consumer Healthcare Drug Product and Solutions

Table 18. Merck & Co. Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 19. Merck & Co. Recent Developments and Future Plans

Table 20. GlaxoSmithKline Company Information, Head Office, and Major Competitors

Table 21. GlaxoSmithKline Major Business

Table 22. GlaxoSmithKline Consumer Healthcare Drug Product and Solutions

Table 23. GlaxoSmithKline Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 24. GlaxoSmithKline Recent Developments and Future Plans

Table 25. Pfizer Company Information, Head Office, and Major Competitors

Table 26. Pfizer Major Business

Table 27. Pfizer Consumer Healthcare Drug Product and Solutions

Table 28. Pfizer Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 29. Pfizer Recent Developments and Future Plans

Table 30. Sanofi Company Information, Head Office, and Major Competitors

Table 31. Sanofi Major Business

Table 32. Sanofi Consumer Healthcare Drug Product and Solutions

Table 33. Sanofi Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 34. Sanofi Recent Developments and Future Plans

Table 35. Takeda Company Information, Head Office, and Major Competitors

Table 36. Takeda Major Business

Table 37. Takeda Consumer Healthcare Drug Product and Solutions

Table 38. Takeda Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 39. Takeda Recent Developments and Future Plans

Table 40. Bayer Company Information, Head Office, and Major Competitors

Table 41. Bayer Major Business

Table 42. Bayer Consumer Healthcare Drug Product and Solutions

Table 43. Bayer Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 44. Bayer Recent Developments and Future Plans

Table 45. Teva Company Information, Head Office, and Major Competitors

Table 46. Teva Major Business

Table 47. Teva Consumer Healthcare Drug Product and Solutions

Table 48. Teva Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 49. Teva Recent Developments and Future Plans

Table 50. Sinopharm Group Company Information, Head Office, and Major Competitors

Table 51. Sinopharm Group Major Business

Table 52. Sinopharm Group Consumer Healthcare Drug Product and Solutions

Table 53. Sinopharm Group Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 54. Sinopharm Group Recent Developments and Future Plans

Table 55. CR Pharmaceutical Company Information, Head Office, and Major Competitors

Table 56. CR Pharmaceutical Major Business

Table 57. CR Pharmaceutical Consumer Healthcare Drug Product and Solutions

Table 58. CR Pharmaceutical Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 59. CR Pharmaceutical Recent Developments and Future Plans

Table 60. Shanghai Pharmaceuticals Company Information, Head Office, and Major Competitors

Table 61. Shanghai Pharmaceuticals Major Business

Table 62. Shanghai Pharmaceuticals Consumer Healthcare Drug Product and Solutions

Table 63. Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 64. Shanghai Pharmaceuticals Recent Developments and Future Plans

Table 65. Hualan Bio Company Information, Head Office, and Major Competitors

Table 66. Hualan Bio Major Business

Table 67. Hualan Bio Consumer Healthcare Drug Product and Solutions

Table 68. Hualan Bio Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 69. Hualan Bio Recent Developments and Future Plans

Table 70. North China Pharmaceutical Company Information, Head Office, and Major Competitors

Table 71. North China Pharmaceutical Major Business

Table 72. North China Pharmaceutical Consumer Healthcare Drug Product and Solutions

Table 73. North China Pharmaceutical Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 74. North China Pharmaceutical Recent Developments and Future Plans

Table 75. Hengrui Medicine Company Information, Head Office, and Major Competitors

Table 76. Hengrui Medicine Major Business

Table 77. Hengrui Medicine Consumer Healthcare Drug Product and Solutions

Table 78. Hengrui Medicine Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 79. Hengrui Medicine Recent Developments and Future Plans

Table 80. Fosun Pharma Company Information, Head Office, and Major Competitors

Table 81. Fosun Pharma Major Business

Table 82. Fosun Pharma Consumer Healthcare Drug Product and Solutions

Table 83. Fosun Pharma Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 84. Fosun Pharma Recent Developments and Future Plans

Table 85. East China Medicine Company Information, Head Office, and Major Competitors

Table 86. East China Medicine Major Business

Table 87. East China Medicine Consumer Healthcare Drug Product and Solutions

Table 88. East China Medicine Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 89. East China Medicine Recent Developments and Future Plans

Table 90. Livzon Group Company Information, Head Office, and Major Competitors

Table 91. Livzon Group Major Business

Table 92. Livzon Group Consumer Healthcare Drug Product and Solutions

Table 93. Livzon Group Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 94. Livzon Group Recent Developments and Future Plans

Table 95. Global Consumer Healthcare Drug Revenue (USD Million) by Players (2018-2023)

Table 96. Global Consumer Healthcare Drug Revenue Share by Players (2018-2023)

Table 97. Breakdown of Consumer Healthcare Drug by Company Type (Tier 1, Tier 2, and Tier 3)

Table 98. Market Position of Players in Consumer Healthcare Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022

Table 99. Head Office of Key Consumer Healthcare Drug Players

Table 100. Consumer Healthcare Drug Market: Company Product Type Footprint

Table 101. Consumer Healthcare Drug Market: Company Product Application Footprint

Table 102. Consumer Healthcare Drug New Market Entrants and Barriers to Market Entry

Table 103. Consumer Healthcare Drug Mergers, Acquisition, Agreements, and Collaborations

Table 104. Global Consumer Healthcare Drug Consumption Value (USD Million) by Type (2018-2023)

Table 105. Global Consumer Healthcare Drug Consumption Value Share by Type (2018-2023)

Table 106. Global Consumer Healthcare Drug Consumption Value Forecast by Type (2024-2029)

Table 107. Global Consumer Healthcare Drug Consumption Value by Application (2018-2023)

Table 108. Global Consumer Healthcare Drug Consumption Value Forecast by Application (2024-2029)

Table 109. North America Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)

Table 110. North America Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)

Table 111. North America Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)

Table 112. North America Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)

Table 113. North America Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)

Table 114. North America Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)

Table 115. Europe Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)

Table 116. Europe Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)

Table 117. Europe Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)

Table 118. Europe Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)

Table 119. Europe Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)

Table 120. Europe Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)

Table 121. Asia-Pacific Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)

Table 122. Asia-Pacific Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)

Table 123. Asia-Pacific Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)

Table 124. Asia-Pacific Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)

Table 125. Asia-Pacific Consumer Healthcare Drug Consumption Value by Region (2018-2023) & (USD Million)

Table 126. Asia-Pacific Consumer Healthcare Drug Consumption Value by Region (2024-2029) & (USD Million)

Table 127. South America Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)

Table 128. South America Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)

Table 129. South America Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)

Table 130. South America Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)

Table 131. South America Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)

Table 132. South America Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)

Table 133. Middle East & Africa Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)

Table 134. Middle East & Africa Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)

Table 135. Middle East & Africa Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)

Table 136. Middle East & Africa Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)

Table 137. Middle East & Africa Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)

Table 138. Middle East & Africa Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)

Table 139. Consumer Healthcare Drug Raw Material

Table 140. Key Suppliers of Consumer Healthcare Drug Raw Materials

List of Figures

Figure 1. Consumer Healthcare Drug Picture

Figure 2. Global Consumer Healthcare Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Consumer Healthcare Drug Consumption Value Market Share by Type in 2022

Figure 4. Solid Preparations

Figure 5. Oral Liquid

Figure 6. Patch

Figure 7. Other

Figure 8. Global Consumer Healthcare Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 9. Consumer Healthcare Drug Consumption Value Market Share by Application in 2022

Figure 10. Hospital Picture

Figure 11. Retail Pharmacy Picture

Figure 12. Other Picture

Figure 13. Global Consumer Healthcare Drug Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 14. Global Consumer Healthcare Drug Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 15. Global Market Consumer Healthcare Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)

Figure 16. Global Consumer Healthcare Drug Consumption Value Market Share by Region (2018-2029)

Figure 17. Global Consumer Healthcare Drug Consumption Value Market Share by Region in 2022

Figure 18. North America Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 19. Europe Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 20. Asia-Pacific Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 21. South America Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 22. Middle East and Africa Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 23. Global Consumer Healthcare Drug Revenue Share by Players in 2022

Figure 24. Consumer Healthcare Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022

Figure 25. Global Top 3 Players Consumer Healthcare Drug Market Share in 2022

Figure 26. Global Top 6 Players Consumer Healthcare Drug Market Share in 2022

Figure 27. Global Consumer Healthcare Drug Consumption Value Share by Type (2018-2023)

Figure 28. Global Consumer Healthcare Drug Market Share Forecast by Type (2024-2029)

Figure 29. Global Consumer Healthcare Drug Consumption Value Share by Application (2018-2023)

Figure 30. Global Consumer Healthcare Drug Market Share Forecast by Application (2024-2029)

Figure 31. North America Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)

Figure 32. North America Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)

Figure 33. North America Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)

Figure 34. United States Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 35. Canada Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 36. Mexico Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 37. Europe Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)

Figure 38. Europe Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)

Figure 39. Europe Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)

Figure 40. Germany Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 41. France Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 42. United Kingdom Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 43. Russia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 44. Italy Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 45. Asia-Pacific Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)

Figure 46. Asia-Pacific Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)

Figure 47. Asia-Pacific Consumer Healthcare Drug Consumption Value Market Share by Region (2018-2029)

Figure 48. China Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 49. Japan Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 50. South Korea Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 51. India Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 52. Southeast Asia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 53. Australia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 54. South America Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)

Figure 55. South America Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)

Figure 56. South America Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)

Figure 57. Brazil Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 58. Argentina Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 59. Middle East and Africa Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)

Figure 60. Middle East and Africa Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)

Figure 61. Middle East and Africa Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)

Figure 62. Turkey Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 63. Saudi Arabia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 64. UAE Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)

Figure 65. Consumer Healthcare Drug Market Drivers

Figure 66. Consumer Healthcare Drug Market Restraints

Figure 67. Consumer Healthcare Drug Market Trends

Figure 68. Porters Five Forces Analysis

Figure 69. Manufacturing Cost Structure Analysis of Consumer Healthcare Drug in 2022

Figure 70. Manufacturing Process Analysis of Consumer Healthcare Drug

Figure 71. Consumer Healthcare Drug Industrial Chain

Figure 72. Methodology

Figure 73. Research Process and Data Source